A Phase I Study of the c-MET Inhibitor Tivantinib in Children with Relapsed or Refractory Solid Tumors
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
We are testing new experimental drugs such as Tivantinib in the hopes of finding a drug that may be effective against tumors that have come back or that have not responded to standard therapy.
Description
We are testing new experimental drugs such as Tivantinib in the hopes of finding a drug that may be effective against tumors that have come back or that have not responded to standard therapy.
Details
| Condition | Solid Tumor |
|---|---|
| Age | 1years - 21years |
| Clinical Study Identifier | TX2948 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.